Breast Cancer
-
VICC’s Arteaga assumes presidency of AACR
Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center (VICC), assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015 during the group’s annual meeting last week in San Diego. Read MoreApr 17, 2014
-
3-D imaging enhances options for breast cancer screening
The Vanderbilt Breast Center at Vanderbilt Health One Hundred Oaks has added tomosynthesis mammography, an imaging technique that creates a three-dimensional image of breast tissue, to help screen patients for breast cancer. Read MoreMar 27, 2014
-
Studies shed new light on breast cancer development
Rebecca Cook, Ph.D., assistant professor of Cancer Biology, has spent her life trying to understand what makes things grow, from seedlings in soil to tumor cells in the body. Read MoreFeb 20, 2014
-
Cancer drug enhances cognition
The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women. Read MoreDec 16, 2013
-
Universitywide Limited Submission Opportunity: Translational cancer research grant from the Mary Kay Foundation
Vanderbilt University may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2014. These awards provide $100,000 over two years for investigators involved in translational research in ovarian, uterine, breast or cervical cancer. The Mary Kay Foundation seeks to fund innovative research that will provide… Read MoreNov 13, 2013
-
Breast SPORE lands NCI renewal
Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). Read MoreNov 7, 2013
-
VU study sheds new light on DNA replication
David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes. Read MoreNov 7, 2013
-
New technique tracks breast cancer subtypes, treatment effectiveness
A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days. Read MoreOct 17, 2013
-
Komen grants bolster breast cancer research
Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research. Read MoreAug 15, 2013
-
Predicting cancer’s response to therapy
Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding. Read MoreJun 24, 2013
-
Disease linked to cell traffic jams
Diseases associated with mutations and changes in expression of the protein caveolin may result from faulty trafficking of the protein to the cell surface. Read MoreJun 20, 2013
-
Breast cancer study explores therapy to slow recurrence
Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer. Read MoreMar 21, 2013
-
Potent genetic risk factor for breast cancer identified
Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer. Read MoreFeb 28, 2013
-
Memorial Gym to go pink for breast cancer awareness
The Vanderbilt Commodores Women’s Basketball team will be decked out in pink uniforms when they take the home court this Sunday, Feb. 10, at 3 p.m., in a matchup against the Kentucky Wildcats. Read MoreFeb 7, 2013
-
Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators. Read MoreDec 7, 2012
-
Polarity protein suppresses tumor growth, invasion
The machinery that builds the characteristic shape of epithelial cells suppresses breast cancer formation and metastasis in a mouse model. Read MoreNov 29, 2012
-
VUCast: Sci-Fi Author
This Week on VUCast: She’s juggling her studies and life as a sci-fi author! Meet writing phenom Kat Zhang. See the new and improved Sarratt/Rand. Which women are more at risk for heart attacks. [vucastblurb]… Read MoreOct 19, 2012
-
More gene links to breast cancer risk
Two newly identified gene variants linked to breast cancer may aid in predicting disease risk and targeting screening and prevention strategies. Read MoreOct 19, 2012
-
Volunteers needed for Race for the Cure and Healthy Living Expo
Susan G. Komen for the Cure is seeking volunteers to help with various tasks from 5 to 11 a.m. on race day, Saturday, Oct. 27. The Komen Race for the Cure will be held at Maryland Farms in Brentwood. To volunteer, contact 2012racevolunteers@gmail.com. In addition, volunteers are needed… Read MoreOct 16, 2012
-
Vanderbilt University Medical Center observes Breast Reconstruction Awareness (BRA) Day
Vanderbilt’s Department of Plastic and Reconstructive Surgery, the Vanderbilt Breast Center and the Vanderbilt University School of Nursing are joining to observe Breast Reconstruction Awareness (BRA) Day at 10 a.m., Wednesday, Oct. 17, at the Vanderbilt Breast Center, located at Vanderbilt Health One… Read MoreOct 16, 2012